US 11607407
Dermal pharmaceutical compositions of 1-methyl-2′,6′-pipecoloxylidide and method of use
granted A61KA61K31/44A61K31/445
Quick answer
US patent 11607407 (Dermal pharmaceutical compositions of 1-methyl-2′,6′-pipecoloxylidide and method of use) held by Relmada Therapeutics, Inc. expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Relmada Therapeutics, Inc.
- Grant date
- Tue Mar 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/44, A61K31/445, A61K47/06, A61K47/08